Top Stories
-
"Precision cancer medicine needs to be envisioned as understanding how cancer works, which goes far beyond individual gene mutations." Read Dr. Bass' Disruptors column for the HICCC.
-
In our Disruptors column, Gordana Vunjak-Novakovic discusses groundbreaking work between engineers and cancer researchers to accelerate personalized therapeutics and better understand the disease.
Topic
-
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
Topic
-
Five teams of researchers are awarded pilot grants to conduct innovative basic science, translational, and clinical research across multiple diseases.
Latest News
- May 11, 2021
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Topic
-
Source:
CUIMC NewsroomOctober 29, 2020Adam Bass, MD, joins the HICCC as the founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
